Literature DB >> 24633894

Novel BRCA1 deleterious mutation (c.1918C>T) in familial breast and ovarian cancer syndrome who share a common ancestry.

Xavier Gabaldó Barrios1, María Desamparados Sarabia Meseguer, José Luis Alonso Romero, Miguel Marín Vera, Gema Marín Zafra, Pilar Sánchez Henarejos, Ana Isabel Sánchez Bermúdez, Francisco Ruiz Espejo.   

Abstract

Mutations in breast cancer susceptibility (BRCA) genes lead to defects in DNA repair processes resulting in elevated genome instability and predisposing to breast and ovarian cancer. We report a novel mutation (c.1918C>T) in the exon 11 of the BRCA1 gene that consists of a nonsense mutation that causes a stop codon downstream in the 640 position of the protein. The mutation was present in two Spanish unrelated families and was associated with four breast cancer cases, including two bilateral breast cancer (one of them synchronous). The median age/mean age (range) was 48.5/44.25 years (27-53). This finding led us to perform haplotype analysis in all family carriers. Four highly polymorphic microsatellite markers were used (17-3858, 17-3930, D17S855, D17S1326) to establish whether or not all these families had a common ancestor. This analysis showed that all mutation carriers of these families had a common haplotype. None of the noncarriers of the mutation or of the 24 healthy controls showed this haplotype. Therefore, the c.1918C>T mutation carriers from these two families allows us to assert that all analyzed mutation carriers share a common ancestry.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24633894     DOI: 10.1007/s10689-014-9708-5

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  13 in total

Review 1.  Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis.

Authors:  Mary Ellen Moynahan; Maria Jasin
Journal:  Nat Rev Mol Cell Biol       Date:  2010-03       Impact factor: 94.444

2.  Identification of the breast cancer susceptibility gene BRCA2.

Authors:  R Wooster; G Bignell; J Lancaster; S Swift; S Seal; J Mangion; N Collins; S Gregory; C Gumbs; G Micklem
Journal:  Nature       Date:  1995 Dec 21-28       Impact factor: 49.962

3.  Cancer incidence and mortality in Spain: estimates and projections for the period 1981-2012.

Authors:  M J Sánchez; T Payer; R De Angelis; N Larrañaga; R Capocaccia; C Martinez
Journal:  Ann Oncol       Date:  2010-05       Impact factor: 32.976

4.  Estimates of cancer incidence and mortality in Europe in 2008.

Authors:  J Ferlay; D M Parkin; E Steliarova-Foucher
Journal:  Eur J Cancer       Date:  2010-01-29       Impact factor: 9.162

Review 5.  BRCA1 and its toolbox for the maintenance of genome integrity.

Authors:  Michael S Y Huen; Shirley M H Sy; Junjie Chen
Journal:  Nat Rev Mol Cell Biol       Date:  2009-12-23       Impact factor: 94.444

6.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

Authors:  Y Miki; J Swensen; D Shattuck-Eidens; P A Futreal; K Harshman; S Tavtigian; Q Liu; C Cochran; L M Bennett; W Ding
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

7.  Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.

Authors:  D F Easton; D T Bishop; D Ford; G P Crockford
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

8.  Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study.

Authors:  S L Neuhausen; S Mazoyer; L Friedman; M Stratton; K Offit; A Caligo; G Tomlinson; L Cannon-Albright; T Bishop; D Kelsell; E Solomon; B Weber; F Couch; J Struewing; P Tonin; F Durocher; S Narod; M H Skolnick; G Lenoir; O Serova; B Ponder; D Stoppa-Lyonnet; D Easton; M C King; D E Goldgar
Journal:  Am J Hum Genet       Date:  1996-02       Impact factor: 11.025

9.  PALB2 functionally connects the breast cancer susceptibility proteins BRCA1 and BRCA2.

Authors:  Fan Zhang; Qiang Fan; Keqin Ren; Paul R Andreassen
Journal:  Mol Cancer Res       Date:  2009-07-07       Impact factor: 5.852

10.  Structure-Function Of The Tumor Suppressor BRCA1.

Authors:  Serena L Clark; Ana M Rodriguez; Russell R Snyder; Gary D V Hankins; Darren Boehning
Journal:  Comput Struct Biotechnol J       Date:  2012-04-01       Impact factor: 7.271

View more
  2 in total

1.  Effect of adriamycin on BRCA1 and PARP-1 expression in MCF-7 breast cancer cells.

Authors:  Hui Wang; Changqing Lu; Yan Tan; Jun Xie; Jingting Jiang
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

2.  Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical-pathological features in BRCA carriers and non-carriers.

Authors:  Xavier Gabaldó Barrios; Mª Desamparados Sarabia Meseguer; Miguel Marín Vera; Ana Isabel Sánchez Bermúdez; José Antonio Macías Cerrolaza; Pilar Sánchez Henarejos; Marta Zafra Poves; Mª Rosario García Hernández; Encarna Cuevas Tortosa; Ángeles Aliaga Baño; Verónica Castillo Guardiola; Pedro Martínez Hernández; Isabel Tovar Zapata; Enrique Martínez Barba; Francisco Ayala de la Peña; José Luis Alonso Romero; José Antonio Noguera Velasco; Francisco Ruiz Espejo
Journal:  Fam Cancer       Date:  2017-10       Impact factor: 2.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.